Ahmet Savran
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Ahmet Savran has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Gonca Dönmez
Department of Medicinal Biology, Faculty of Medicine, Niğde Ömer Halisdemir University, Niğde 51240, Turkey
4 shared publications - Işıl Aydemir
Department of Histology and Embryology, Faculty of Medicine, Niğde Ömer Halisdemir University, Niğde, Turkey
4 shared publications - İsmail Sari
Department of Medicinal Pharmacology, Faculty of Medicine, Niğde Ömer Halisdemir University, Niğde 51240, Turkey
4 shared publications - Oktay Özkan
Department of Pharmacology, Faculty of Medicine, Nigde Omer Halisdemir Unversity, Nigde, Turkey
4 shared publications - Fatma Esin Kırık
Department of Medical Microbiology Faculty of Medicine Nigde Ömer Halisdemir University Niğde Turkey
3 shared publications - Mehmet İbRahim Tuglu
MANİSA CELÂL BAYAR ÜNİVERSİTESİ, TIP FAKÜLTESİ
3 shared publications
Latest Publications
- Open Access
- 16 November 2017
- Published by MDPI AG in Proceedings
- Vol. 1 (10) , 990
The Effect of Lysimachia savranii on the Migration of the Breast Cancer Cells
The treatment of breast cancer includes chemotherapy, radiotherapy and chemotherapy. Recently, alternative agents have been searched for breast cancer, especially medicinal plants because their anti-cancer effects. It has been reported that the genus of Lysimachia has anti-proliferative effect on cancer cells. In our study we aimed to evaluate in vitro anti-cancer activity of Lysimachia savranii on migration of breast cancer cells. Breast cancer cell lines MCF-7 and MDA-MB-231 and also adipose tissue derived mesenchymal stem cells as normal cells. IC50 doses of Lysimachia savranii extract and Doxorubicin for each cells were calculated via MTT assay. In vitro wound model with (+) plus shape was created using pipette tips for migration analysis and IC50 doses were exposed. The oxidative stress, vascularization and apoptosis were analyzed by immunocytochemical staining of eNOS, iNOS, VEGF and TUNEL. Data was evaluated by Graphpad software using one-way analysis of variance. Lysimachia savranii and Doxorubicin have anti-proliferative effect on breast cancer cells. Breast cancer cell migration was inhibited by Lysimachia savranii. There was an increase of eNOS and iNOS stainings, and apoptotic cells whereas there was a decrease of VEGF staining. Our findings indicate that Lysimachia savranii extract is a potential herbal product for breast cancer therapy.
- 16 November 2017
- Published by MDPI AG in Proceedings
- Vol. 1 (10) , 990
Open AccessThe Effect of Lysimachia savranii on the Migration of the Breast Cancer Cells
The treatment of breast cancer includes chemotherapy, radiotherapy and chemotherapy. Recently, alternative agents have been searched for breast cancer, especially medicinal plants because their anti-cancer effects. It has been reported that the genus of Lysimachia has anti-proliferative effect on cancer cells. In our study we aimed to evaluate in vitro anti-cancer activity of Lysimachia savranii on migration of breast cancer cells. Breast cancer cell lines MCF-7 and MDA-MB-231 and also adipose tissue derived mesenchymal stem cells as normal cells. IC50 doses of Lysimachia savranii extract and Doxorubicin for each cells were calculated via MTT assay. In vitro wound model with (+) plus shape was created using pipette tips for migration analysis and IC50 doses were exposed. The oxidative stress, vascularization and apoptosis were analyzed by immunocytochemical staining of eNOS, iNOS, VEGF and TUNEL. Data was evaluated by Graphpad software using one-way analysis of variance. Lysimachia savranii and Doxorubicin have anti-proliferative effect on breast cancer cells. Breast cancer cell migration was inhibited by Lysimachia savranii. There was an increase of eNOS and iNOS stainings, and apoptotic cells whereas there was a decrease of VEGF staining. Our findings indicate that Lysimachia savranii extract is a potential herbal product for breast cancer therapy.
- Open Access
- 16 November 2017
- Published by MDPI AG in Proceedings
- Vol. 1 (10) , 988
The Cytotoxic Effect of Lysimachia savranii on the Neuroblastoma Cells
Neuroblastoma cells have been used for antitumoral mechanisms such as stopping the cell cycle and inducing apoptosis. The genus of Lysimachia is studied to determine its anti-proliferative effect. The aim of this study is to show the cytotoxic effect of Lysimachia savranii on neuroblastoma cells in vitro conditions. Neuroblastoma cells and mesenchymal stem cells were cultured and treated with the extract of Lysimachia savranii and IC50 dose was evaluated. The effects on cell viability, oxidative stress, neurite inhibition and apoptosis of Lysimachia savranii at dose of IC50 were studied. In neuroblastoma cells, the rates of eNOS and iNOS stainings used for analysis of oxidative stress were greater than mesenchymal stem cells, and the difference was statistically significant (p < 0.005). TUNEL assay to determine cell apoptosis in neuroblastoma cells was greater than mesenchymal stem cells and also the difference was statistically significant (p < 0.005). The effects of Lysimachia savranii was showed out in vitro on neuroblastoma cells and this plants can be analysis for its cytotoxic effect in vivo models.
- 16 November 2017
- Published by MDPI AG in Proceedings
- Vol. 1 (10) , 988
Open AccessThe Cytotoxic Effect of Lysimachia savranii on the Neuroblastoma Cells
Neuroblastoma cells have been used for antitumoral mechanisms such as stopping the cell cycle and inducing apoptosis. The genus of Lysimachia is studied to determine its anti-proliferative effect. The aim of this study is to show the cytotoxic effect of Lysimachia savranii on neuroblastoma cells in vitro conditions. Neuroblastoma cells and mesenchymal stem cells were cultured and treated with the extract of Lysimachia savranii and IC50 dose was evaluated. The effects on cell viability, oxidative stress, neurite inhibition and apoptosis of Lysimachia savranii at dose of IC50 were studied. In neuroblastoma cells, the rates of eNOS and iNOS stainings used for analysis of oxidative stress were greater than mesenchymal stem cells, and the difference was statistically significant (p < 0.005). TUNEL assay to determine cell apoptosis in neuroblastoma cells was greater than mesenchymal stem cells and also the difference was statistically significant (p < 0.005). The effects of Lysimachia savranii was showed out in vitro on neuroblastoma cells and this plants can be analysis for its cytotoxic effect in vivo models.
- Open Access
- 15 November 2017
- Published by MDPI AG in Proceedings
- Vol. 1 (10) , 991
Investigation of Cytotoxic Effect of Origanum minutiflorum on Cancer Cells
The number of breast cancer cases have increased gradually in women. During treatment of the breast cancer, chemotherapy needs adjuvant agents. Medicinal plants have an anticancerogenic effect in such cases. Our aim is to search the cytotoxic effect of Origanum minutiflorum O. Schwarz & P.H. Davis on breast cancer cells in vitro conditions. For this purpose MDA-MB-231 and MCF-7 breast cancer cell lines and adipose tissue derived mesenchymal stem cells were used. Oregano oil from Origanum minutiflorum was exposed to the all cells and IC50 dose was calculated by MTT assay. The immunocytochemical staining of eNOS, p53, PCNA and TUNEL at IC50 dose for each cells. The results were evaluated using one-way-ANOVA by Graphpad software. The proliferation of breast cancer cells were inhibited by oregano oil. Oregano oil did not show any cytotoxic effect in mesenchymal stem cells. It was determined that cytotoxic effect of oregano oil on cancer cells was occurred through increase of eNOS and p53 staining for survival and the TUNEL labeling for apoptosis, and decreased of PCNA staining for proliferation. According to our data, oregano oil has cytotoxic effect on breast cancer cell lines, and it needs to be analysis to detect active components for other biological activities.
- 15 November 2017
- Published by MDPI AG in Proceedings
- Vol. 1 (10) , 991
Open AccessInvestigation of Cytotoxic Effect of Origanum minutiflorum on Cancer Cells
The number of breast cancer cases have increased gradually in women. During treatment of the breast cancer, chemotherapy needs adjuvant agents. Medicinal plants have an anticancerogenic effect in such cases. Our aim is to search the cytotoxic effect of Origanum minutiflorum O. Schwarz & P.H. Davis on breast cancer cells in vitro conditions. For this purpose MDA-MB-231 and MCF-7 breast cancer cell lines and adipose tissue derived mesenchymal stem cells were used. Oregano oil from Origanum minutiflorum was exposed to the all cells and IC50 dose was calculated by MTT assay. The immunocytochemical staining of eNOS, p53, PCNA and TUNEL at IC50 dose for each cells. The results were evaluated using one-way-ANOVA by Graphpad software. The proliferation of breast cancer cells were inhibited by oregano oil. Oregano oil did not show any cytotoxic effect in mesenchymal stem cells. It was determined that cytotoxic effect of oregano oil on cancer cells was occurred through increase of eNOS and p53 staining for survival and the TUNEL labeling for apoptosis, and decreased of PCNA staining for proliferation. According to our data, oregano oil has cytotoxic effect on breast cancer cell lines, and it needs to be analysis to detect active components for other biological activities.
- Open Access
- 10 November 2017
- Published by MDPI AG in Proceedings
- Vol. 1 (10) , 1026
The Neurotoxic Effects of Origanum minutiflorum
The natural products are promising products for anti-proliferative effects in cancer. In this study our aim was to analyze the neurotoxic effect of Origanum minutiflorum O. Schwarz & PH. Davis on neuroblastoma cells in in vitro conditions. The neuroblastoma cells were treated with Oregano oil from Origanum minutiflorum and doxorubicin, and cytotoxic activities of these agents were evaluated by MTT assay for IC50 doses. The immunocytochemistry staining of eNOS, iNOS and TUNEL assay were performed. The results were analyzed using Graphpad software for one-way-ANOVA. The immunoreactivities of eNOS and iNOS were increased in neuroblastoma cells treated with oregano oil and doxorubicin. Both of Oregano oil and doxorubicin showed inhibitory activity against neuroblastoma cells via oxidative stress. Also the number of apoptotic cells was greater than the control group. The oregano oil enhanced the cytotoxic activity of doxorubicin. The compound of oregano oil should be considered with the other neuroblastoma cells for neurotoxicity.
- 10 November 2017
- Published by MDPI AG in Proceedings
- Vol. 1 (10) , 1026
Open AccessThe Neurotoxic Effects of Origanum minutiflorum
The natural products are promising products for anti-proliferative effects in cancer. In this study our aim was to analyze the neurotoxic effect of Origanum minutiflorum O. Schwarz & PH. Davis on neuroblastoma cells in in vitro conditions. The neuroblastoma cells were treated with Oregano oil from Origanum minutiflorum and doxorubicin, and cytotoxic activities of these agents were evaluated by MTT assay for IC50 doses. The immunocytochemistry staining of eNOS, iNOS and TUNEL assay were performed. The results were analyzed using Graphpad software for one-way-ANOVA. The immunoreactivities of eNOS and iNOS were increased in neuroblastoma cells treated with oregano oil and doxorubicin. Both of Oregano oil and doxorubicin showed inhibitory activity against neuroblastoma cells via oxidative stress. Also the number of apoptotic cells was greater than the control group. The oregano oil enhanced the cytotoxic activity of doxorubicin. The compound of oregano oil should be considered with the other neuroblastoma cells for neurotoxicity.